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Abstract
Objective/Background: The Global Fund to Fight AIDS, Tuberculosis & Malaria (GF) strives for high value for
money, encouraging countries to integrate synergistic services and systems strengthening to maximize investments.
The GF needs to show how, and how much, its grants support more than just HIV/AIDS, TB and malaria.
Sexual and Reproductive Health (SRH) has been part of HIV/AIDS grants since 2007. Previous studies showed the GF
PBF system does not allow resource tracking for SRH integration within HIV/AIDS grants. We present findings from
a resource tracking case study using primary data collected at country level.
Methods: Ethiopia was the study site. We reviewed data from four HIV/AIDS grants from January 2009-June 2011
and categorized SDAs and activities as directly, indirectly, or not related to SRH integration. Data included: GF PBF
data; financial, performance, in-depth interview and facility observation data from Ethiopia.
Results: All HIV/AIDS grants in Ethiopia support SRH integration activities (12-100%). Using activities within SDAs,
expenditures directly supporting SRH integration increased from 25% to 66% for the largest HIV/AIDS grant, and
from 21% to 34% for the smaller PMTCT-focused grant. Using SDAs to categorize expenditures underestimated
direct investments in SRH integration; activity-based categorization is more accurate.
The important finding is that primary data collection could not resolve the limitations in using GF GPR data for
resource tracking. The remedy is to require existing activity-based budgets and expenditure reports as part of PBF
reporting requirements, and make them available in the grant portfolio database. The GF should do this quickly, as
it is a serious shortfall in the GF guiding principle of transparency.
Conclusions: Showing high value for money is important for maximizing impact and replenishments. The Global
Fund should routinely track HIV/AIDs grant expenditures to disease control, service integration, and overall health
systems strengthening. The current PBF system will not allow this. Real-time expenditure analysis could be achieved
by integrating existing activity-based financial data into the routine PBF system. The GF’s New Funding Model and
the 2012-2016 strategy present good opportunities for over-hauling the PBF system to improve transparency and
allow the GF to monitor and maximize value for money.
Keywords: Resource tracking, Global Fund, HIV, SRH, Diagonal financing, Service integration, Health systems
strengthening, Ethiopia
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Background
The Global Fund to Fight AIDS, Tuberculosis & Malaria
(GF) is a leading financier of global health initiatives. In
2012, the GF celebrated its 10th anniversary, and by
2014, had committed more than USD 32 billion to
grants in more than 150 countries. The majority of these
funds support the three disease areas that the GF was
launched to address: HIV/AIDS control activities (52%),
followed by malaria (29%), and tuberculosis (15%) [1].
Traditionally, the GF has encouraged countries to integrate related, synergistic services in order to maximize
investments, and has opened new grant channels to specifically support these areas. The GF grant portfolio currently funds both TB-HIV integration (2%) and health
systems strengthening (HSS) (2%) [1].
The GF provides its financing through a performancebased funding (PBF) model – it tracks achievement of
targets promised in the proposals, and disburses committed funds accordingly, with rewards for good performance, and some penalties for poor performance in
the form of delays in receiving resources. The PBF
model, which requires grant recipients to submit Grant
Performance Reports (GPRs) on a regular basis, introduced a higher degree of transparency on the value of
GF funding than previously, as the GF also committed
to make data on grant progress publicly available. The
large volume of GF funding, along with the PBF model
and a grant-making approach that is country-led, have
contributed to significant declines in deaths and infections from the three targeted diseases, and have helped
forge a stronger link between funding and grant performance [2].
Pressing challenges to the current GF model are evident, despite successes. After an initial surge in funding
to combat HIV/AIDS, tuberculosis, and malaria, the
post-2008 economic climate has meant that financing
streams have stabilized or diminished; this in turn has
led to increasing demands that recipient countries allocate funds to demonstrably effective interventions, and
provide co-financing. The GF recognized the necessity
of revamping its investment strategy in 2011, articulated
in its 2012-2016 strategy, “Investing for Impact”, where
the concept of value for money is highly visible. Promoting and demonstrating maximized value for money
presents a particular challenge for the GF, with its country-owned and led resource allocation model, and the integration and HSS it has encouraged within grants [2-5].
Showing high value for money ultimately will require the
GF to estimate the value of investments made within its
vertical, disease-targeted funds in synergistic areas, such
service integration and health systems strengthening.
One such area is investment in Sexual and Reproductive Health (SRH). The GF has encouraged integration of
within its HIV/AIDS grants since 2007, after SRH-HIV
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integration was put forth as a priority and best practice
by the World Health Organization, World Bank, and
others [6,7]. Efficiencies that can be gained through
HIV-SRH program linkages and service integration offer
one way to purchase more health for every dollar of GF
investment, and multiple organizations have since produced guidance and technical support to countries on
how to do this [6,8].
In 2009 and 2010, WHO conducted two studies to assess the progress on SRH-HIV integration in GF HIV/
AIDS grants. Both used the existing GF grant portfolio
database. The first examined the extent to which SRH
programmatic elements had been included in GF HIV
proposals and grant agreements [9]. The authors examined 134 approved HIV/AIDS proposals between Rounds
1 through 7 and found that four broad elements pertaining to SRH were included in 70% of the proposals, but
were found in a lower proportion of the corresponding
signed grant agreements. For example, the diagnosis and
treatment of sexually transmitted infections (STIs) was
found in 69% of the HIV-related proposals but in only
54% of the corresponding grant agreements. The second
study assessed the extent to which SRH interventions can
be monitored in Global Fund performance frameworks
[10]. The authors examined grant performance report
(GPR) data on 252 signed HIV/AIDS grants. They found
that 94% of the HIV grant programs supported what
looked to be SRH activities, but could gather little evidence on success in actual service integration or outcomes
related to HIV-SRH integration, primarily due to inadequacy of SRH-related performance indicators included in
the monitoring framework.
The combined results from these two studies showed
that the data publicly available through GF Secretariat –
including approved proposals, signed grant agreements,
performance monitoring frameworks, GPRs, and expenditures by service delivery area (SDA) - even when examined together, do not allow tracking of resources
allocated to SRH integration within HIV/AIDS grants.
The increasing frustration with the limited understanding of SRH-HIV integration this data allowed prompted
the WHO and GF to collaborate on a study that would
track SRH integration resources by collecting data at
country level. The hope was that a case study of one
country would support the development of a methodology for tracking SRH-HIV resources that could be applied in other countries. Here we present the findings
from the resulting country-level resource tracking study
to understand investments in SRH integration made
through GF HIV/AIDS grants in Ethiopia.

Study purpose

This study intended to investigate the following questions:
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1. In the selected proposals identified as including
sexual and reproductive elements, what amount of
funds was allocated to sexual and reproductive
health activities in the corresponding grant
agreement?
2. What has been the correspondence between the
budget and selected expenditure categories for the
SRH-related activities in the grant agreements?
3. Is there evidence that the additional funding has
actually been allocated to sexual and reproductive
health activities of the program that Global Fund
grant(s) support?

Methods
A case study methodology was developed to understand
how investments supported by the Global Fund’s HIV/
AIDS grants are used for sexual and reproductive health
services at the country level. It was designed to build on
the data available through Global Fund grant performance
monitoring system while incorporating more detailed and
varied data from country level. This study did not require
ethical approval, as it used existing data. Informed consent
for interviews was obtained verbally, using a letter of
introduction from the GF (Additional file 1).
Case selection

Ethiopia was selected as the study site from a short list of
countries that receive significant amounts through GF
HIV/AIDS grants and had strong references to SRH integration, as identified through the previous WHO studies in
2009 and 2010. As of 2014, the GF had committed 1.75
billion USD to Ethiopia, of which more than 1 billion USD
(62%) is for HIV/AIDS grants. Three HIV/AIDS grants
were made to Ethiopia in Round 7 under the proposal
titled, “Ensuring Quality HIV/AIDS Services by Consolidating and Strengthening Existing HIV/AIDS Prevention,
Treatment, Care and Support Programs.” Of these, only
one was thought to include SRH activities after review of
the grant proposal and agreements (ETH-708-G08-H; see
Table 1), but all three Round 7 grants were included in this
study. Consultation with GF clarified that the Rolling
Continuation Channel (RCC) for the Round 2 grant (ETH202-G03-H-00) should also be included. In all, four HIV/
AIDS grants were included in this case study (Table 1).
These four grants approved a total of $331,358,836 for
Ethiopia, the largest being the RCC grant to the government’s HIV/AIDS Prevention and Control Office
(HAPCO). The Round 7 proposal titled, “Ensuring Quality
HIV/AIDS Services by Consolidating and Strengthening
Existing HIV/AIDS Prevention, Treatment, Care and
Support Programs”, awarded smaller grants to three PRs:
HAPCO, and two non-government organizations, the
Ethiopian Interfaith Forum for Development Dialogue
and Action (EIFDDA) and the Network of Networks of
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HIV Positives in Ethiopia (NEP+). We reviewed data from
January 2009, when the grants began, through June 2011,
as June 2011 marked the end of the most recent quarter
for which expenditure data was available.
Framework for categorizing costs and expenditures

As the purpose of the expenditure analysis was to assess investments in SRH made through Ethiopia’s active HIV/
AIDS grants, we needed to allocate budget and expenditure
amounts to SRH service linkage areas. We used the 2005
“A Framework for Priority Linkages” (Figure 1), in keeping
with the approach used in earlier studies [9,10], to
categorize HIV/AIDS grant activities as one of the
following:
1. Directly integration related: program activities for
SRH (family planning, maternal, neonatal and child
health, sexually transmitted infections), HIV/AIDS
(prevention only), as well as the key linkage areas in the
2005 Framework (HIV status awareness; promotion of
safe sex; STI and HIV service connection; integration of
HIV/AIDS into MNCH).
2. Indirectly integration related: activities contributing
to health systems strengthening, such as human
resources, supply chain, infrastructure and
institution strengthening, and M&E
3. Non-integration related: activities supporting
income-generating activities for PLWHA (IGA),
blood safety, and opportunistic infections.
Background information on GF financial data and
reporting systems

Budget, disbursement, and expenditure data for GF grants
are tracked by the Principal Recipients (PRs), who report to
the Local Funding Agent (LFA), who reports to the GF
Secretariat. Each of these three forms of financial data
(budget, disbursement, and expenditure) contains costs at
the level of Service Delivery Area (SDA), which are broad
categories that contain many distinct activities (e.g.,
Behavior Change Communication or PMTCT), and may
vary from year to year. For example, SDA 1.1, PMTCT, in
ET-708-G08-H, includes 12 activities in Year 1, and nine in
Year 2. SDA 9, Institutional Strengthening, in ET-202-G03H-00, has five activities in year 1, four in Year 2, and two in
Year 3 (tables a-d, Additional file 2).
Detailed grant budgets are generated by PRs as a part of
the proposal process and submitted for review as a part of
the proposal. These budgets are then typically modified
during the grant agreement negotiations, and an adjusted
budget, by SDA, is included with the signed grant
agreement (Figure 2). However, the signed budget by activity level is not included in the agreement, nor is it publicly
available. These are kept by the Secretariat, PR, and LFA,
and were made available to the study team not in original

Grant and PR

Grant number

Time period analyzed

RCC HAPCO

ETH-202-G03-H-00 Jan 2009 – Jun 2011 (2.5 years)
+ (Life of Grant: Jan09 – Dec14;
6 years)

Amount requested*

Amount approved**

Amount disbursed***

Amount expended***

$273,882,281++($707,702,367) $297,493,992(109%
of requested) ($435,001,702)

$179,234,054(60% of
approved)

$30,142,540(17% of
disbursed)

$41,777,416($49,506,807)

$41,666,516(100%
of requested) ($41,666,516)

$35,728,140(86% of
approved)

$11,662,571(33% of
disbursed)

$17,429,768(99% of
approved)

$13,774,229(79% of
disbursed)

Round 7 HAPCO ETH-708-G08-H

Jan 2009 – Dec 2010 (2 years)
(Life of Grant: 3 years requested,
2 years approved – Jan09-Dec10)

Round 7 EIFDDA ETH-708-G09-H

Jan 2009 – Jun 2011 (2.5 years)
$17,326,041++($31,997,188)
(Life of Grant: Jan09-Dec13; 5 years)

$17,546,192(101%
of requested) $30,177,691

Round 7 NEP+

Apr 1, 2009 – Sep 2011 (2.5 years) $12,152,136++($24,757,588)
(Life of Grant: Apr09-Mar13; 5 years)

$12,177,176(100%
$12,647,639(104% of
of requested) ($23,226,898+++) approved)

ETH-708-G07-H
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Table 1 Active Global Fund HIV/AIDS grants in Ethiopia, December 2011

$11,068,009(88% of
disbursed)

*

From grant proposal; **From grant agreement, *** Provided by the LFA.
Note: First disbursement not until September 2010.
++
Figure estimated from proposal budget using year one plus year two plus one half of year three amounts, as quarterly breakdown is not provided in proposal budget.
+++
Amount in grant agreement differs from amount provided in GF online grant portfolio financial overview.
+
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Figure 1 SRH-HIV integration framework.

format, but as part of the first phase Budget Extraction by
the GF Secretariat, and as expenditure reports by the LFA.
For two grants in Ethiopia (ETH-202-G03-00 and ETH708-G08-H), we were able to track expenditures by
activities within SDAs.
The GF also requires PRs to report expenditures
according to 8 pre-defined cost categories that it applies
across it grant portfolio (Table 2). The Secretariat’s
budget extraction included an analysis by these standard
cost categories:
1. Communication materials
2. Health Products and Health Equipment

3.
4.
5.
6.
7.
8.

Human Resources
Infrastructure
Living Support to Clients
Medicines and Pharmaceutical Products
Monitoring and Evaluation
Overheads

GPRs report progress according to goals, objectives, and
targets, by each performance indicator included in the
grant agreement. Most of these targets, especially those
set for the first 3 years of grant implementation, are outputs, and others reflect the results of several different activities, making the currently reported indicators difficult

Figure 2 Financial data used to assess SRH integration in GF HIV/AIDS grants.
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Table 2 SRH Resource tracking in GF HIV grants, Ethiopia case study data collection
Data collection phase Purpose

Dates

1

Identify costs and performance
indicators related to sexual and
reproductive health in the selected
country grants

June-September 2011 Budget allocations by SDA, activity
and Cost Category

2

Obtain complete grant budget,
Septemberdisbursement, and expenditure
November 2011
data from LFA and PRs; understand
program and budget allocation
changes made between proposal
and negotiated grant agreement;
further specify through discussion
with key informants which grant
program activities can be
considered SRH-integration related

Grant budgets, disbursements and
expenditures, by PR; by activity
within SDAs for RCC; SRH and HIV/
AIDS performance statistics; drugs
and supplies data from PFSA;
MNCH, RH, PMTCT, ANC, and HIV/
AIDS policies and recent review
reports; and National Health
Accounts (NHA) data, including the
HIV/AIDS and RH sub-accounts

LFA; grant PRs; FMOH;
FHAPCO; PFSA Central;
WHO; UNAIDS; UNFPA;
UNICEF; other in-country
partners

3

Further specify through observation December 2011
of health facilities how SRH
integration is realized, to
understand impact of GF
integration-related funds

Regional HAPCO budgets,
disbursements, and expenditures;
regional SRH and HIV/AIDS
performance data; Regional PFSA
data; health facility integration
maps

Amhara and Addis
Ababa regions: 3 FMOH
health centers in each;
RHB; Regional PFSA
Hubs

to use for assessing integration of SRH and HIV/AIDS.
An indicator such as the numbers of condoms distributed
is both a family planning and STI and HIV prevention activity, and therefore straightforward to interpret in terms
of integration; numbers of people tested for HIV is more
difficult to understand in terms of SRH integration unless
the context of the target groups and test promotion strategies being used by the activities is considered. Indicators
specific to SRH are not currently a part of the GF PBF.
Data collection

Data collection proceeded in three phases (Table 2), of
which only the first two were part of the original study
plan. The third phase was added after it was confirmed
that the data needed to improve expenditure categorization
were not available at the central level in Ethiopia.
In the first phase, the GF Secretariat provided an initial budget extraction, by SDA, activity and Cost Category, using the final costed workplans that accompany
the signing of the grant agreements, but which are not
publicly available (the methodology used by the Secretariat is provided in Appendix A).
The second phase focused on data collection at the national level, in Ethiopia, including; budgets, disbursements and current expenditures, by PR and by activity
within SDAs when possible. To provide context for the
prioritized SRH activities identified in the expenditure
reports, we also reviewed current and historical SRH
and HIV/AIDS performance statistics; MNCH, RH,
PMTCT, ANC, and HIV/AIDS policies and recent review reports; and National Health Accounts (NHA) data,
including the HIV/AIDS and Reproductive Health subaccounts. In addition, 28 in-depth interviews with key
stakeholders were conducted primarily in the second

Data collected

Data sources
GF Secretariat; GF
website

phase of data collection to gain deeper understanding of
the grant negotiation process, grant implementation
challenges, SRH integration and PMTCT priorities, and
how SRH, PMTCT and integration policies were being
implemented through programs in general.
Financial data used for the resource tracking analysis
were collected from three sources (GF Secretariat, Ethiopia’s Local Funding Agent (LFA), Ethiopia’s HIV/AIDS
grant Principal Recipients) and checked for consistency
across sources and reconciled when needed, before
analysis. Reconciliation was rarely necessary because
Ethiopia’s GF HIV/AIDS grants had recently been
audited. Data from the LFA were used for analysis as it
was in a consistent format across all three PRs. These
data included: most current expenditures and disbursement reports, and negotiated budgets; grant performance reports, grant proposals, and grant agreements.
Performance data for SRH and HIV/AIDS integration
focused primarily on available PMTCT-related indicators, but also included condoms distributed, test kits distributed, and facilities provided with STI testing and
treatment supplies. Most recent GPRs for each grant
and annual FMOH reports generated (EFY 2001, 2002,
and 2003) were used to identify GF HIV/AIDS grant
contributions to overall SRH performance.
After reviewing available financial and program performance data, the study team recognized that a deeper
understanding of the SRH, HIV/AIDS and GF grant negotiation processes was necessary, to boost confidence
in how we categorized expenditures and estimates SRH
integration investments. In particular, we needed further
clarification on how expenditures were allocated within
SDAs that included both SRH and non-SRH integration
activities. Central-level key informants confirmed that
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the necessary information would likely be available at
the health facility level, and encouraged the team to conduct facility visits to triangulate information on SRHHIV integration.
Health facility visits in the third phase of data collection focused on two regions, Amhara and Addis Ababa.
These were selected as positive deviant cases; Amhara
because of demonstrated progress in integration (also
because of the presence of development partners that
are providing technical support to SRH-HIV integration), and Addis Ababa because of the substantial HIV
burden. Three health facilities were selected from each
region: 1 hospital and 2 health centers. In addition, program performance and expenditures data were collected
from Regional Health Bureaus (RHBs), Regional HAPCOs, and Regional PFSAs, and interviews conducted
with 21 additional key informants at regional and facility
levels. The study team mapped the integration of SRH
and HIV services at the facility level, as well as patient
flow among the services. In addition, the study team
conducted interviews with health facility managers, SRH
and HIV service providers, and on some occasions, clients, to better understand how SRH-HIV integration
was working and potentially offering increased efficiency
of services and ease of navigation to beneficiaries and
providers alike. This information was used in this study
to refine and triangulate the categorization of SRHrelated expenditures, in order to improve the estimation
of GF investment being made through HIV/AIDS grants.
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For example, Activity 2.1.3 (“Accommodation services
for key health professionals and night duty staffs in 50
remote health centers”, in SDA 2), is categorized as
Human Resources in the signed budget, but tracked as
Infrastructure by the PR and LFA. This one activity
accounted for 14% of the total budget amount for ET708-G08-H, and so significantly affected comparisons by
cost category that any interpretation of results was
difficult.
Expenditure analysis for SRH investment

A large proportion of active Global Fund HIV-AIDS
grants in Ethiopia are being expended on activities that
support the integration of SRH services, either directly
or indirectly (12-100%, Figure 3).
Analysis by SDA

Using SDAs as the unit of analysis, all four active HIV/
AIDS grants included activities that at least indirectly supported integration of SRH activities (12-62%, Figure 3),
but only ETH-202-G03-H-00 and ET-708-G08-H included activities directly related to SRH integration (25%
and 41%). The other two grants included only indirectlyrelated SRH integration activities; 12% and 30% of
expenditures supported these SRH. Using SDAs, 100%
of ET-708-G08-H grant expenditures and 88% of ETH202-G03-H-00 grant expenditures were supporting
SRH integration either directly or indirectly (Figure 3).
Analysis by activity

Study findings
Budget and expenditure comparative analysis

A comparison of the proposal budgets, signed budgets,
and expenditures by SRH-related category was conducted at the grant level to determine for which service
delivery areas the budget was adjusted and how, as a
part of the negotiation process (Tables a-d, Additional
file 2). We could not identify appreciable differences between proposal amounts and budgeted amounts by
SDA. We were unable to assess any budget adjustments
to activities within SDAs, as there was not correspondence between costed SDAs and activities in the signed
budgets, and the original proposals. We noted that none
of the directly-related SRH integration categories
seemed to be missing in the signed budgets, as compared to the proposals. We also noted that, of the four
linkage areas, none of the four HIV/AIDS grants in
Ethiopia seemed to address the third linkage area,
“optimize connections between HIV/AIDS and STI services” (Table 3).
When we tried to track expenditures according to the
GF cost categories, we found many costs were categorized differently in PR records compared with budgets in
proposals and costed activity-based workplan budgets.

We analyzed expenditure by activities within SDA, for
two grants for which the data were available, and which
were the only grants to include activities directly related
to SRH integration: ETH-202-G03-H-00 and ET-708G08-H. For ETH-202-G03-H-00, the proportion of
expenditures directly supporting SRH integration
increases from 25% to 66% when activities within SDAs
are categorized according to SRH integration investment. For ET-708-G08-H, which is focused on PMTCT,
the proportion of expenditures directly supporting SRH
integration increase from from 21% to 34% when activities are the unit of analysis (Table 4).
Most of the re-categorization of expenditures stemmed
from health systems strengthening activities hidden in
SDAs that were assumed to be indirect investment in SRH
integration, but upon examination of specific activities,
turned out to include direct investment. For example, the
major difference in ETH-202-G08-H-00 estimates of direct
investment comes from an activity within SDA 9: Institutional Strengthening, originally categorized as indirect investment. But after it was found to include the activity,
“Upgrading and equipping 187 rural health facilities to provide HCT, PMTCT and ART services,”, the expenditures
for this activity within the SDA were re-categorized as
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Table 3 Direct integration-related expenditures by key linkage area*, using activity categories
ET-202-G03-H-00

ET-708-G08-H

Total expenditures (% of directly
integration-related expenditures
for both grants)

A. Learn HIV Status and Access Services

$4,089,481

$0

$4,089,481 (14.7%)

B. Promote Safer and Healthier Sex

$1,247,661

$0

$1,247,661 (4.5%)

C. Optimize the Connection Between HIV and STI Services

$0

$0

$0 (0%)

D. Integrate HIV/AIDS with Maternal and Infant Health

$0

$8,009,064

$8,009,064 (28.8%)

Multiple Linkage Areas+

$14,439,628

$0

$14,439,628 (52.0%)

TOTAL

$19,776,770

$8,009,064

$27,785,834

*Linkage areas based on the WHO et al. Sexual and Reproductive Health & HIV/AIDS: A Framework for Priority Linkages (2005);
+Two activities in the RCC grant involved multiple linkage areas.

direct investment, which more than doubled the grant total
of direct SRH integration-related expenditures. The
principal difference for ET-708-G08-H stems from the
SDA “Human Resources”; breaking these expenditures
down by activity showed that approximately 12% of the
total expenditures within this SDA were direct, not indirect, investments in SRH-HIV integration.

Discussion
We present our discussion under two themes. First, we
discuss the interpretation of the resource tracking results, and then, perhaps more importantly, we discuss
the experiences of conducting this resource tracking
study, and implications for the GF and its ability to demonstrate and maximize value for money.

investment being made by Ethiopia’s GF HIV/AIDS grants
in SRH integration. In the case of ETH-202-G08-H-00 and
ET-708-G08-H, using SDAs underestimates the direct
investment that GF HIV/AIDS grants make in SRH integration. There is no sound way to hypothesize whether this
would be the case with other HIV/AIDS grants in Ethiopia,
or in other countries; using SDAs could just as easily
over-estimate investment in SRH-HIV integration, depending on how SDAs were written in the original grant proposal and affected in the grant negotiation process. In the
absence of activity-specific expenditure availability, SDAbased expenditure analysis findings should be interpreted
with great caution, in particular if there has been significant
negotiation at the time of grant agreement signature.

Interpreting the study results

Conducting resource tracking for GF grants
Categorizing costs and expenditures

This study found that in Ethiopia, Global Fund HIV-AIDS
grants provide substantial investment for both SRH integration. Changing the unit of analysis from SDA to activities
significantly changed our estimations of direct v. indirect

From the first steps of analysis, we found that neither the
routinely reported SDA nor the cost categories were
useful for understanding how GF HIV/AIDS grant resources are used for investment in SRH-HIV integration.

Figure 3 HIV grant expenditure distribution for SRH integration, by SDA, as of June 2011.
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Table 4 Comparison of SRH integration investment, by SDA and by activity
Expenditures through June 2011:

Directly integration related

Indirectly integration related

Non integration related

Total
$30,142,540

ET-202-G03-H-00 (Source: LFA data)
By SDA

By Activity

$7,699,594

$18,562,575

$3,880,371

26%

62%

13%

$19,776,770

$6,485,399

$3,880,371

66%

22%

13%

$6,889,224

$16,878,968

$0

21%

79%

0%

$8,009,062

$15,759,130

$0

34%

66%

0%

$30,142,540

ET-708-G08-H (Source: PR data)
By SDA

By Activity

The first challenge was that there is no way to map the
budgeted amounts in the Component Budget of a proposal to activities within SDAs. Proposed budgets and
signed budgets can be mapped to expenditures by SDA.
But as we describe, each SDA contains a multitude of activities, some of which pertain to SRH integration and
some which do not. The GF also uses cost categories in
proposal and signed budgets; these, however, are not prospectively used for expenditure tracking by PRs, who
retro-fit expenditures to cost categories prescribed by the
GF. In doing so, we found several SDAs and activities
within SDAs that were categorized differently by PRs and
LFAs than in the signed budgets (e.g., human resources
categorized as infrastructure; health products categorized
as infrastructure). Like the SDAs, the cost categories are
broad, and within each is a mix of activities that either relate to SRH integration or not.
There were further problems, when we sought to track
resources by cost category and SDA. When we examined
the expenditure reports and costed workplans from the
LFA, we found that several activities had moved from
one SDA to another, or could not be identified at all in
the expenditure reports. This may have been the result
of grant negotiations, but there was no documentation
of the specific changes. HIV and SRH stakeholders in
Ethiopia all identified that the grant negotiation process
had resulted in significant re-programming and refinement of activities, so that the SDAs in the signed grant
agreement do not give a clear enough picture of what
activities are actually being implemented. One objective
of our in-depth interviews with PRs and CCM members
was to try and get a clearer understanding of the differences we noted between signed agreement and expenditure reports; these showed that many activities changed
from the time of the proposal until the grant agreement
was signed – including an adjusted timeline – but memories were not complete, and with an absence of documentation, we did not have the scope to verify and
validate what was reported from different sources.

$23,768,192

$23,768,192

The SDAs as articulated in grant agreements are simply too broad to allow for meaningful resource tracking
of Global Fund grants, without accompanying details on
activity implementation plans. Even the implementing
partners in Ethiopia did not find the SDA categories to
be useful – yet the grant agreement and budgets still use
SDAs as the primary unit of analysis. The more accurate
and useful unit of analysis for budgets and expenditures
is the activity.
Data availability

Our findings point to the significant limitations in using
the existing Global Fund grant performance monitoring
systems to get a full picture of SRH-HIV integration.
Although implementing partners track expenditures by
activity within SDAs, and provide the LFA with activitybased expenditure reports, the GF Secretariat does not
currently require PRs to report expenditures by activity
for the grant performance reports (GPRs) that are part
of the performance-based financing system. The GF also
does not make the costed, activity-based budgets that
are signed at the time of grant agreement publicly available, further hindering use of the GF Secretariat’s PBF
database for useful resource tracking and expenditure
analysis.
As noted in previous studies [9,10], the lack of agreed
upon SRH-HIV integration–related indicators is a major
hindrance to monitoring progress on integration, and
this study encountered the same limitation, to the extent
that it was not possible to link grant expenditures with
progress on SRH or HIV-SRH integration indicators. As
one example, PMTCT indicators are directly related to
SRH-HIV integration and linkage, and presented the
clearest opportunity for analyzing expenditures and performance achievement. However, the GPR data for the
Ethiopia PMTCT grant was in numbers instead of the
required percentage format, and it was unclear whether
a cumulative target or period-specific target was shown.
For other SRH linkage areas, specific indicators were
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mostly absent from the grant agreements and the GPRs.
The Global Fund continues to work with partners to develop a better monitoring framework. That said, there is
much room for improving definitions and formulations
of the few SRH-related indicators that currently are part
of the Global Fund M&E Framework.
Activity-based cost and expenditure reporting is essential for accurate resource tracking of GF grant monies.
Without activity-specific grant program information, a
clear picture of how Global Fund grant monies are actually being used cannot be formulated, and, as we show,
SDA-based expenditure analysis cannot be interpreted
with confidence. The challenges to doing activity-based
analysis are not insignificant. We found that even after
getting detailed data that is not publicly available, including the costed activity-based budgets from the GF
Secretariat, it was necessary to collect data directly from
PRs and the LFA. We also needed to interview stakeholders in Ethiopia to get a better understanding of what
was actually happening with grant activities, and actually
observe how SRH-HIV integration was being implemented in clinical settings, in order to more accurately
categorize expenditures. Collecting data by going to
country level, and then to health facility level within the
country, was essential for understanding SRH-HIV integration. The lack of activity-based expenditure reporting
maintained as part of the GF PBF database place severe
limitations on conducting routine resource tracking for
GF grants, as the resources needed to do studies using
primary data collection at country level are great.
The vast amount of data available through the GF’s PBF
system are tempting to use for many types of financial and
performance analysis. However, users of this information
need to be made aware of the serious limitations. The
grant negotiation process introduces much opacity into the
data, obscuring linkages between proposals, budgets, and
expenditures; activity-based financial data are not made
available; and, there is often a lack of relevant performance
indicators that can be linked to specific activities, further
limiting meaningful analysis. Other studies have been similarly frustrated by the opacity of the GF budgeting, grant
negotiation, and spending records [3,5,10-12].

Synergistic service integration and diagonal investments of
GF grants

GF grant budgets and GPRs are constructed to support
monitoring of achievements in the designated grant
areas: HIV/AIDS, TB, malaria, HSS, and TB-HIV. However, this is possible only using SDAs as the unit of
analysis, and we show the serious limitations of this approach. In the case of trying to understand integration
of synergistic services, or HSS, SDA-based analysis presents even more challenges.
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Some activities were clear and easy to allocate to SRHHIV integration and linkage areas; for example, HIV
testing and counseling of pregnant women, PMTCT
prophylaxis, condom distribution and other family planning services, and sexual health behavior change interventions are specific examples of critical services in both
the HIV and SRH realms. PMTCT services, the primary
intersection of SRH and HIV/AIDS programming for
treatment and care, were also considered to be directly
integration related. Health systems strengthening activities were hypothesized to support both SRH and HIV
service activities, although it could not be known whether
these were specifically facilitating the integration of these
two programs. Interviews and discussions with key stakeholders in HIV, MNCH, SRH, and PMTCT, and observations of six health centers in Ethiopia, helped us to
determine that we should consider these expenditures to
be indirectly related to SRH-HIV integration. Consultations with all stakeholders confirmed that the broad SDA
categories mixed activities that directly and indirectly support SRH-HIV integration; therefore, the study team
worked with the LFA to obtain activity-based expenditures
for more accurate categorization and estimation.
Trying to examine GF grants using information in the
Secretariat’s Grant Performance Monitoring and management systems gives one a sense that there is little
documentation of what is actually going on at country
level. These are important barriers to formulating a better picture of how Global Fund grants support more
than just HIV/AIDS, TB and malaria, through either service integration or health systems strengthening support
– or to put it another way, to better understand what
value is there for GF grant money. These barriers are especially important to overcome as the GF moves forward
with implementing its New Funding Model [13] and the
Investing for Impact strategy [2].
Diagonal financing is an important concept that supports the GF approach to investing primarily in three
specific diseases [14]. This is based on the idea that programs targeting these diseases must be accompanied by
activities that more broadly support the development of
resilient health systems, in order to maximize long-term
success, and therefore, value for money. These include
investments in training and expansion of the health
workforce, integration and coordination with other disease programs, strengthening supply chain, laboratories,
monitoring and evaluation functions, as well as increasing access to services through health financing such as
universal health coverage [14,15]. If we consider the GF’s
future direction and strategic approach, the GF has recently re-affirmed its commitment to investing in HSS
[16]. The GF has been investing in HSS from the beginning, both through direct grant mechanisms and diagonally through grants for the three diseases. However, it
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will face similar challenges to demonstrating value for
HSS money as we faced with resource tracking for SRHHIV integration. Just documenting the amount of funds
investing in building resilient health systems will be difficult; looking only at HSS grants will be serious underestimation, and the SDAs of disease-specific grants mask
significant amounts of HSS activities that are a challenge
to assess. This will be a significant weakness as the GF
seeks to demonstrate its value for money, important
both for maximizing impact and for maximizing replenishments. The Global Fund should be able to estimate,
on a regular basis, how its HIV/AIDs grants are supporting the relatively neglected area of reproductive health,
through integration of SRH, or how HIV-AIDS grants
contribute to overall health systems strengthening –
among other things. The current PBF data monitoring
system will not allow this without fundamental changes
to reporting requirements.

Conclusions
This study found that publicly available grant information had to be triangulated with in-country financial
reports and key stakeholders regarding the grant negotiation and budget signing process, before we could reasonably categorize expenditures for analysis. Even with
such detailed, triangulated information, we were unable
to track resources for all the HIV/AIDS grants to SRH
integration achievements, and unable to propose a replicable methodology. We believe that using SDAs as the
primary organizing unit for GPR data is one of the problems, and the lack of documentation on the grant negotiation and effort to link submitted proposals with
signed grant agreements is another. Limited performance indicators that are meaningful for linking expenditures with program achievements are yet another
problem. A simple step to remedy the first set of financial data problems is to make existing activity-based
budgets and expenditure reports publicly available.
It is not at all clear why the GF Secretariat does not require activity-based expenditure reporting, or make the
costed activity budgets available in the grant portfolio
database. The information exists, and is routinely verified
at country level. The same situation is likely found in
other countries; PRs have the motivation to monitor the
activities and expenditures of their sub-recipients. But the
GF Secretariat either does not maintain this information
itself or wish to make it publicly available. This is a serious
shortfall in transparency, one of the GF’s central guiding
principles.
Despite the fact that the necessarily adaptive nature of
GF grant implementation in pursuit of “country ownership” can make real-time expenditure analysis and classification challenging, this is not a reason to avoid doing it.
In fact, it could be achieved in the interim by integrating
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costed activity workplans into the GF’s routine performance monitoring system. The new funding model and the
2012-2016 strategy present good opportunities for overhauling the PBF system to improve transparency and to
allow the GF to actually track resources expended, so they
can use this information to maximize value for money.

Appendix A
Description of Methodology for Budget Extraction,
WHO-Global Fund Sexual and Reproductive Health
case study – Ethiopia*
Final detailed budgets were collected for the following grants: Round 2 RCC and Round 7, Phase 1. The
“All data” tab contains all activities listed in the final,
approved, detailed budgets for these grants (not publicly accessible). The tab “SDA analysis” contains activities only for those SDAs of interest in this research.
Cost categories for each activity were assigned by the PR
and the global amount was recorded and reported to the
Global Fund (as reflected in the Grant Agreement. PRs
are not required to submit line by line analysis by cost category to the Global Fund. Therefore, we are not able to
provide this data, and in our analysis, the aggregated
amount by cost category may not exactly reflect the aggregated cost category amounts as listed in the grant agreement. To be able to do analysis by cost category, each
activity was mapped to a cost category, as defined in the
Budget Guidelines.
The “Summary” tab contains aggregates for each SDA
of interest, and the share of the budget for each SDA by
year. The “Pivot” tab contains totals by cost category by
year, and by grant.
N.B. For RCC, the Grant Agreement amount lists the
total as US $ 63 298 605, however the actual amount according to the final detailed budget is $51, 154,748. The
difference (approx. US $12 mil) is due to the fact that
Activity 9.1.1. upgrading and equipping rural health facilities was delayed from Year 1 into year 2.
*provided by the GF Secretariat.
Additional files
Additional file 1: Letter of introduction used for informed consent.
Additional file 2: Table a. Comparison of expenditure types for ET708-G08-H, by SDA and by activity. Table b: Expenditures by Service
Delivery Area and by Activity for ETH-708-G08-H. Table c. Comparison of
Expenditure Types for ETH-202-G03-H-00, by SDA and by Activity. Table d.
ETH-202-G03-H-00 – Expenditures by Service Delivery Area and by Activity:
January 2009 – June 2011.
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